
1. Short title
This Act may be cited as the Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023. 2. Reauthorization of sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment
Section 1106(b)(6) of the Public Health Service Act (42 U.S.C. 300bâ€“5(b)(6)) is amended by striking 2019 through 2023 and inserting 2024 through 2028.  
